BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Inventories
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Inventories of $9.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $4.35M.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $4.85M, a 457.13% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $515.00K, a 76.19% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.69M, a 11.32% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2025 was $1.64M, a 60.64% decline from fiscal 2024.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2024 was $4.16M, a 187.17% increase from fiscal 2023.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2023 was $1.45M, a 88.33% decline from fiscal 2022.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2022 was $12.42M, a 41.70% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.20M 10-Q · filed 2026-08-05 | $9.71M derived: sum of 3 quarters · filed 2026-08-05 | $11.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $4.85M 10-Q · filed 2026-05-06 | $5.36M derived: sum of 2 quarters · filed 2026-05-06 | $7.05M derived: sum of 3 quarters · filed 2026-05-06 | $5.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.21M derived: sum of 2 quarters · filed 2026-02-26 | $769.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.64M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $254.00K derived: sum of 2 quarters · filed 2026-08-05 | $1.12M 10-Q · filed 2025-11-04 | $3.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$568.00K 10-Q · filed 2026-08-05 | $1.59M derived: sum of 3 quarters · filed 2026-08-05 | $3.12M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $870.00K 10-Q · filed 2026-05-06 | $3.03M derived: sum of 2 quarters · filed 2026-05-06 | $4.55M derived: sum of 3 quarters · filed 2026-05-06 | $3.81M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.68M derived: sum of 2 quarters · filed 2026-02-26 | $2.94M derived: sum of 3 quarters · filed 2026-02-26 | $4.16M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $781.00K derived: sum of 2 quarters · filed 2025-11-04 | $2.00M 10-Q · filed 2025-11-04 | $1.09M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $481.00K 10-Q · filed 2025-08-05 | -$426.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.96M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.22M 10-Q · filed 2025-05-06 | $313.00K derived: sum of 2 quarters · filed 2026-02-26 | $3.70M derived: sum of 3 quarters · filed 2026-02-26 | $2.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$907.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.48M derived: sum of 2 quarters · filed 2026-02-26 | $1.58M derived: sum of 3 quarters · filed 2026-02-26 | $1.45M 10-K · filed 2026-02-26 |
| 2023-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.49M derived: sum of 2 quarters · filed 2024-11-05 | $2.36M 10-Q · filed 2024-11-05 | $3.52M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.03M 10-Q · filed 2024-08-06 | $131.00K derived: sum of 3 quarters · filed 2025-02-25 | $3.81M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$131.00K 10-Q · filed 2024-05-07 | $1.03M derived: sum of 2 quarters · filed 2025-02-25 | $4.70M derived: sum of 3 quarters · filed 2025-02-25 | $11.94M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $4.83M derived: sum of 2 quarters · filed 2025-02-25 | $12.07M derived: sum of 3 quarters · filed 2025-02-25 | $12.42M 10-K · filed 2025-02-25 |
| 2022-09-30 | $3.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $10.91M derived: sum of 2 quarters · filed 2023-11-08 | $11.26M 10-Q · filed 2023-11-08 | $13.40M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $7.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $7.59M 10-Q · filed 2023-08-07 | $9.73M derived: sum of 3 quarters · filed 2024-02-27 | $13.55M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $354.00K 10-Q · filed 2023-05-08 | $2.49M derived: sum of 2 quarters · filed 2024-02-27 | $6.31M derived: sum of 3 quarters · filed 2024-02-27 | $11.05M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $5.96M derived: sum of 2 quarters · filed 2024-02-27 | $10.69M derived: sum of 3 quarters · filed 2024-02-27 | $8.77M 10-K · filed 2024-02-27 |
| 2021-09-30 | $3.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $8.56M derived: sum of 2 quarters · filed 2022-11-04 | $6.63M 10-Q · filed 2022-11-04 | $7.43M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $4.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $2.81M 10-Q · filed 2022-08-05 | $3.61M derived: sum of 3 quarters · filed 2023-02-27 | $4.62M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | -$1.93M 10-Q · filed 2022-05-09 | -$1.13M derived: sum of 2 quarters · filed 2023-02-27 | -$121.00K derived: sum of 3 quarters · filed 2023-02-27 | $5.11M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $798.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.81M derived: sum of 2 quarters · filed 2023-02-27 | $7.04M derived: sum of 3 quarters · filed 2023-02-27 | $7.04M 10-K · filed 2023-02-27 |
| 2020-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $6.24M derived: sum of 2 quarters · filed 2021-11-04 | $6.24M 10-Q · filed 2021-11-04 | $4.46M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $5.23M 10-Q · filed 2021-08-09 | $3.46M derived: sum of 3 quarters · filed 2022-02-28 | $4.23M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | -$1.78M derived: sum of 2 quarters · filed 2022-02-28 | -$1.00M derived: sum of 3 quarters · filed 2022-02-28 | -$600.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$1.00M derived: sum of 2 quarters · filed 2022-02-28 | -$600.00K derived: sum of 3 quarters · filed 2022-02-28 | -$1.65M 10-K · filed 2022-02-28 |
| 2019-09-30 | $776.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.18M derived: sum of 2 quarters · filed 2020-11-06 | $127.00K 10-Q · filed 2020-11-06 | $955.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$649.00K 10-Q · filed 2020-08-07 | $179.00K derived: sum of 3 quarters · filed 2021-03-01 | $779.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.05M 10-Q · filed 2019-05-09 | -$221.00K derived: sum of 2 quarters · filed 2021-03-01 | $379.00K derived: sum of 3 quarters · filed 2021-03-01 | $593.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $828.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.43M derived: sum of 2 quarters · filed 2021-03-01 | $1.64M derived: sum of 3 quarters · filed 2021-03-01 | $1.65M 10-K · filed 2021-03-01 |
| 2018-09-30 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $814.00K derived: sum of 2 quarters · filed 2019-11-08 | $821.00K 10-Q · filed 2019-11-08 | $821.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $221.00K 10-Q · filed 2019-08-08 | $221.00K derived: sum of 3 quarters · filed 2020-03-13 | -$1.08M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $7.00K 10-Q · filed 2019-05-09 | $7.00K derived: sum of 2 quarters · filed 2020-03-13 | -$1.30M derived: sum of 3 quarters · filed 2020-03-13 | -$648.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$1.30M derived: sum of 2 quarters · filed 2020-03-13 | -$655.00K derived: sum of 3 quarters · filed 2020-03-13 | -$500.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$655.00K derived: sum of 2 quarters · filed 2018-11-08 | -$500.00K 10-Q · filed 2018-11-08 | -$2.23M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $805.00K 10-Q · filed 2018-08-09 | -$927.00K derived: sum of 3 quarters · filed 2019-03-14 | -$644.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $155.00K 10-Q · filed 2018-05-09 | -$1.58M derived: sum of 2 quarters · filed 2019-03-14 | -$1.29M derived: sum of 3 quarters · filed 2019-03-14 | -$1.29M derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$1.45M derived: sum of 2 quarters · filed 2019-03-14 | -$1.45M derived: sum of 3 quarters · filed 2019-03-14 | -$1.11M 10-K · filed 2019-03-14 |
| 2016-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $283.00K derived: sum of 2 quarters · filed 2017-11-08 | $620.00K 10-Q · filed 2017-11-08 | $2.23M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $337.00K 10-Q · filed 2017-08-08 | $1.95M derived: sum of 3 quarters · filed 2018-03-12 | $641.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $337.00K 10-Q · filed 2017-05-08 | $1.95M derived: sum of 2 quarters · filed 2018-03-12 | $641.00K derived: sum of 3 quarters · filed 2018-03-12 | $739.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $304.00K derived: sum of 2 quarters · filed 2018-03-12 | $402.00K derived: sum of 3 quarters · filed 2018-03-12 | $929.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$1.21M derived: sum of 2 quarters · filed 2016-11-08 | -$683.00K 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $98.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $625.00K 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $527.00K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $683.00K 10-K · filed 2017-02-27 | |||
| 2012-12-31 | -$263.00K 10-K · filed 2015-03-02 | |||
| 2011-12-31 | -$635.00K 10-K · filed 2014-03-10 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$9.00K derived: sum of 2 quarters · filed 2013-03-11 | -$5.38M 10-K · filed 2013-03-11 | |
| 2010-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | -$5.38M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$5.37M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $6.28M 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |